Revenue

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Integrated Biologics Revenue	3.65B
Advanced Synthesis Revenue	1.61B
Specialized Modalities Revenue	1.03B
Corporate Revenue	237.00M

Adjusted EBITDA

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Integrated Biologics Core EBITDA	1.29B
Advanced Synthesis Core EBITDA	674.00M
Specialized Modalities Core EBITDA	176.00M
Corporate Core EBITDA	-73.00M

Updated Dec 31, 2025. Data Source: Fiscal.ai.